Global Urinalysis Test Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Urinalysis Test Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Sep 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Urinalysis Test Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 4.16 Billion
Diagram Market Size (Forecast Year)
USD 8.29 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Abbott (US)
  • Medtronic (US)
  • Siemens (Germany)
  • General Electric Company (US)
  • BD (US)

Global Urinalysis Test Market Segmentation, By Product (Consumables, Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes) - Industry Trends and Forecast to 2031.

Urinalysis Test Market

Urinalysis Test Market Analysis

The concentration, appearance, and content of urine are all checked during a urinalysis test. Abnormal urinalysis findings may indicate a sickness or disease. If the urine test is positive, it could indicate that the kidneys are not functioning properly or filtering the blood as they should. It could potentially be a sign of cardiovascular disease. Urinalysis can also be performed to determine whether or not a woman is pregnant or ovulating.

Urinalysis Test Market Size

Global urinalysis test market size was valued at USD 4.16 billion in 2023 and is projected to reach USD 8.29 billion by 2031, with a CAGR of 9.00% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Urinalysis Test Key Market Insights

Segmentation

  • By Product: Consumables, Instruments
  • By Test Type: Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis
  • By Application: Disease Screening, Pregnancy and Fertility
  • By End User: Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

Abbott (US), Medtronic (US), Siemens (Germany), General Electric Company (US), BD (US), Thermo Fisher Scientific (US), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (US), Sysmex Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Beckman Coulter Inc. (US), ACON Laboratories Inc. (US), ARKRAY Inc. (Japan), Penn Medicine Lancaster General Health. (US), BioMaxima SA (Poland), Quidel Corporation (US), Metropolis India (India), Dr Lal PathLabs (India) and Trinity Biotech (Ireland).

Market Opportunities

  • The increased prevalence of UTIs, diabetes, and renal and liver illnesses
  • The growing geriatric population
  • Increase in age-related diseases.

Urinalysis Test Market Definition

Urinalysis tests are a group of tests that use urine as a sample to detect symptoms of a variety of disorders. It's one of the most important tests for detecting any indicators of liver illness, diabetes, or kidney disease. Chemical evaluation, microscopic examination, and gross examination are the three types of urinalysis tests.

Urinalysis Test Market Dynamics

Drivers

  • Rise in the geriatric population

The prevalence of age-related disorders such as diabetes, liver, and renal disease is predicted to rise dramatically as the senior population grows, further accelerating the growth of the market.

  • Growing prevalence of urinary tract infection

One of the primary elements propelling the market forward is the rising prevalence of urinary tract infections (UTIs) in developing economies. If left untreated, urinary tract infections (UTIs) can spread to the kidneys and cause birth difficulties in pregnant women, contributing to market growth.

  • Increase in the incidence of chronic kidney diseases globally

Furthermore, the 13.3 million people worldwide who suffer from acute kidney injury (AKI) each year are at risk of developing CKD or renal failure in the coming years which is further anticipated to propel the growth of the market.

Opportunities

In addition, the technological development in urine analyzers is further estimated to provide potential opportunities for the growth of the urinalysis test market in the coming years.

Restraints/Challenges

On the other hand, the accessibility of refurbished urine analyzers is further projected to impede the growth of the urinalysis test market in the targeted period. However, the shift in the regulatory landscape might further challenge the growth of the urinalysis test market in the near future.

This urinalysis test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Urinalysis Test Market

The pandemic of COVID-19 has had a huge impact on the urinalysis test market. COVID-19 patients are more likely to have acute kidney damage (AKI), leading to major health problems, including death. As a result, patients are advised to see a nephrologist on a frequent basis to avoid any further health concerns. However, in the post-COVID scenario, Companies have made strategic decisions to implement COVID-19 rapid tests, maintain revenues, and mitigate COVID-19's impact on their operating capabilities.

Urinalysis Test Market Scope

The urinalysis test market is segmented on the basis of product, test type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Consumables
  • Instruments

On the basis of product type, the urinalysis test market is segmented into consumables and instruments. Consumables are further segmented into pregnancy and fertility kits, dipsticks, disposables, and reagents. Instruments are further segmented into automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. Biochemical urinalysis are further segmented into laboratory tests and point-of-care tests.

Test Type

  • Pregnancy and Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

On the basis of test type, the urinalysis test market is segmented into pregnancy and fertility tests, biochemical urinalysis and sediment urinalysis.

Application

  • Disease Screening
  • Pregnancy
  • Fertility

On the basis of application, the urinalysis test market is segmented into disease screening, and pregnancy and fertility. Disease screening is further segmented into urinary tract infections, kidney diseases, diabetes, liver diseases and other disease screening applications.

End user

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Laboratories and Institutes

On the basis of end user, the urinalysis test market is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes.

Urinalysis Test Market Regional Analysis          

The urinalysis test market is analysed and market size insights and trends are provided by country, product, test type, application, and end user as referenced above.

The countries covered in the urinalysis test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the urinalysis test market due to the increase in the cases of chronic diseases related to liver and kidney, diabetes. Furthermore, the development in technology will further boost the growth of the urinalysis test market in the region during the forecast period.

Asia-Pacific is projected to observe a significant amount of growth in the urinalysis test market due to the rise in technological developments by local companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Urinalysis Test Market Share

The urinalysis test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinalysis test market.

Urinalysis Test Market Leaders Operating in the Market Are:

  • Abbott (US)
  • Medtronic (US)
  • Siemens (Germany)
  • General Electric Company (US)
  • BD (US)
  • Thermo Fisher Scientific (US)
  • 77 Elektronika Kft (Hungary)
  • Bio-Rad Laboratories Inc. (US)
  • Sysmex Corporation (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Cardinal Health (US)
  • Beckman Coulter Inc. (US)
  • ACON Laboratories Inc. (US)
  • ARKRAY Inc. (Japan)
  • Penn Medicine Lancaster General Health. (US)
  • BioMaxima SA (Poland)
  • Quidel Corporation (US)
  • Metropolis India (India)
  • Dr Lal PathLabs (India)
  • Trinity Biotech (Ireland)

Latest Developments in Urinalysis Test Market

  • In August 2020, Siemens Healthineers has granted Sysmex America, Inc. exclusive rights to distribute and service the Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use in North America


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Product (Consumables, Instruments), Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes) - Industry Trends and Forecast to 2031. .
The Global Urinalysis Test Market size was valued at USD 4.16 USD Billion in 2023.
The Global Urinalysis Test Market is projected to grow at a CAGR of 9% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott (US), Medtronic (US), Siemens (Germany), General Electric Company (US), BD (US), Thermo Fisher Scientific (US), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (US), Sysmex Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Beckman Coulter Inc. (US), ACON Laboratories Inc. (US), ARKRAY Inc. (Japan), Penn Medicine Lancaster General Health. (US), BioMaxima SA (Poland), Quidel Corporation (US), Metropolis India (India), Dr Lal PathLabs (India), Trinity Biotech (Ireland).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.